hotspot -WSS

hotspot

author：hotspot 2025-10-02 18:47:15 - browse：119

The 7 a.m. Acela out of South Station in Boston trembled along the rails toward Manhattan. David Sabatini sat alone on the left side of the train. He had brought along a science paper to work on, but had a lot on his mind. He kept his Wordle streak alive on his phone, and stared out at the picturesque Connecticut coastline. His clothing hung loose from recent weight loss, presumably from stress.

It was Jan. 4, 2022, a brisk sunny day. The tall, gangling scientist with a long mess of black hair had once generated Nobel Prize buzz for his discoveries in biology. But at that moment, he was unemployed in his 50s, his reputation ruined, spending many nights in his brother’s guest room or on his ex-wife’s sofa, so emotionally distraught that his family was afraid to leave him alone.

Sabatini was journeying to New York in search of a new beginning, an against-all-odds comeback.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Medicare drug price negotiation continues, as pharma counteroffers

knowledge

WSS

How to bring more disabled researchers into academia

Why Talkspace is targeting Medicare, a tricky market

Streamlined flu vaccines recommended by FDA advisory panel

The problem with charging patients to message their doctors

Streamlined flu vaccines recommended by FDA advisory panel

Streamlined flu vaccines recommended by FDA advisory panel

leisure time

hotspot

knowledge

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

The public health thinking behind the CDC’s new Covid guidance

Activists slam private health insurers over coverage restrictions

Stem cell biologist probes earliest stages of human development

Medical leaders decry Supreme Court decision on affirmative action

Amylyx ALS drug fails large clinical trial

Tori Bowie and the unacceptable rates of Black maternal death

State of the Union pitch: Bigger Medicare drug price negotiations

DIEP, the 'gold standard' of breast reconstruction, is under threat

With psoriasis trial ahead, Alumis raises $259 million

explore

Lack of health data on LGBTQ+ people has serious consequences

Medicare drug price negotiation continues, as pharma counteroffers

Harvard's David Sinclair gets blowback over aging

The untold story of TV’s first prescription drug ad

Air quality improving but still lags in Black, Hispanic communities

A new approach to psychiatric drug development

leisure time

knowledge

entertainment

knowledge